{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:32:18Z","timestamp":1785472338183,"version":"3.56.0"},"reference-count":207,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Information on invasive aspergillosis (IA) and other invasive filamentous fungal infections is limited in non-neutropenic patients admitted to the intensive care unit (ICU) and presenting with no classic IA risk factors. This review is based on the critical appraisal of relevant literature, on the authors' own experience and on discussions that took place at a consensus conference. It aims to review risk factors favoring aspergillosis in ICU patients, with a special emphasis on often overlooked or neglected conditions. In the ICU patients, corticosteroid use to treat underlying conditions such as chronic obstructive pulmonary disease (COPD), sepsis, or severe COVID-19, represents a cardinal risk factor for IA. Important additional host risk factors are COPD, decompensated cirrhosis, liver failure, and severe viral pneumonia (influenza, COVID-19). Clinical observations indicate that patients admitted to the ICU because of sepsis or acute respiratory distress syndrome are more likely to develop probable or proven IA, suggesting that sepsis could also be a possible direct risk factor for IA, as could small molecule inhibitors used in oncology. There are no recommendations for prophylaxis in ICU patients; posaconazole mold-active primary prophylaxis is used in some centers according to guidelines for other patient populations and IA treatment in critically ill patients is basically the same as in other patient populations. A combined evaluation of clinical signs and imaging, classical biomarkers such as the GM assay, and fungal cultures examination, remain the best option to assess response to treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Lay summary<\/jats:title><jats:p>The use of corticosteroids and the presence of co-morbidities such as chronic obstructive pulmonary disease, acute or chronic advanced liver disease, or severe viral pneumonia caused by influenza or Covid-19, may increase the risk of invasive aspergillosis in intensive care unit patients.<\/jats:p><\/jats:sec>","DOI":"10.1093\/mmy\/myab064","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T18:01:11Z","timestamp":1634752871000},"source":"Crossref","is-referenced-by-count":38,"title":["Aspergillosis: Emerging risk groups in critically ill patients"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8391-3988","authenticated-orcid":false,"given":"Stefan","family":"Kluge","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Center Hamburg \u2013 Eppendorf, Hamburg, D-20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Strau\u00df","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, Medizinische Klinik 1, University Hospital Erlangen, Erlangen, D-91054, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4766-4651","authenticated-orcid":false,"given":"Matthias","family":"Kochanek","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, D-50937, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A","family":"Weigand","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, D-69120, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Rohde","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, D-20246, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Lahmer","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Innere Medizin II, Klinikum rechts der Isar der Technischen Universit\u00e4t Munich, Munich, D-81675, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"2021120812115643300_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"2021120812115643300_bib2","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00134-019-05789-6","article-title":"Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies","volume":"45","author":"Pardo","year":"2019","journal-title":"Intensive Care Med"},{"key":"2021120812115643300_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0039-1696968","article-title":"Invasive pulmonary aspergillosis in nonimmunocompromised hosts","volume":"40","author":"Tudesq","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"2021120812115643300_bib4","doi-asserted-by":"crossref","first-page":"i39","DOI":"10.1093\/jac\/dkx032","article-title":"Invasive mold infections in the ICU setting: complexities and solutions","volume":"72","author":"Bassetti","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021120812115643300_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib6","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Hematologica"},{"key":"2021120812115643300_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humpath.2018.02.025","article-title":"Autopsy-detected diagnostic errors over time in the intensive care unit","volume":"76","author":"Tejerina","year":"2018","journal-title":"Hum Pathol"},{"key":"2021120812115643300_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/myc.12927","article-title":"Invasive aspergillosis in critically ill patients: an autopsy study","volume":"62","author":"Tejerina","year":"2019","journal-title":"Mycoses"},{"key":"2021120812115643300_bib9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00134-017-4731-2","article-title":"Intensive care medicine research agenda on invasive fungal infection in critically ill patients","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med"},{"key":"2021120812115643300_bib10","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the european confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021120812115643300_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijantimicag.2019.01.002","article-title":"The contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports","volume":"53","author":"Jeong","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2021120812115643300_bib12","first-page":"10","article-title":"Mucormycosis: the clinical evolution of a fungal superpathogen","volume":"58","author":"Kontoyiannis","year":"2015","journal-title":"Mycoses"},{"key":"2021120812115643300_bib13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cid\/cis195","article-title":"Mucormycosis in organ and stem cell transplant recipients","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/myc.12862","article-title":"Invasive mucormycosis in children with cancer: a retrospective study from the infection working group of italian pediatric hematology oncology association","volume":"62","author":"Muggeo","year":"2019","journal-title":"Mycoses"},{"key":"2021120812115643300_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-016-2005-1","article-title":"Invasive mucormycosis in children: an epidemiologic study in european and non-European countries based on two registries","volume":"16","author":"Pana","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2021120812115643300_bib16","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0039-3401992","article-title":"Mucormycosis","volume":"41","author":"Reid","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"2021120812115643300_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/mmy\/myx017","article-title":"Diabetes mellitus as the major risk factor for mucormycosis in mexico: epidemiology, diagnosis, and outcomes of reported cases","volume":"56","author":"Corzo-Leon","year":"2017","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, france, 2001-2010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2021120812115643300_bib21","doi-asserted-by":"crossref","first-page":"ofy187","DOI":"10.1093\/ofid\/ofy187","article-title":"Epidemiology and clinical features of invasive fungal infection in a US health care network","volume":"5","author":"Webb","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2021120812115643300_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"2021120812115643300_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.idc.2017.05.005","article-title":"Invasive fungal infections in the intensive care unit","volume":"31","author":"Ostrosky-Zeichner","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"2021120812115643300_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Critical Care"},{"key":"2021120812115643300_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.idcr.2018.02.011","article-title":"Issues in the management of invasive pulmonary aspergillosis in non-neutropenic patients in the intensive care unit: a role for isavuconazole","volume":"12","author":"Bassetti","year":"2018","journal-title":"IDCases"},{"key":"2021120812115643300_bib26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/jac\/dkx527","article-title":"Epidemiology of invasive aspergillosis and triazole-resistant aspergillus fumigatus in patients with hematological malignancies: a single-centre retrospective cohort study","volume":"73","author":"Lestrade","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2021120812115643300_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with hematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"2021120812115643300_bib28","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/jac\/dkz258","article-title":"Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in hematology patients","volume":"74","author":"Resendiz-Sharpe","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021120812115643300_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/myc.12838","article-title":"Diagnosis of invasive fungal diseases in hematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German Society for Hematology and Medical Oncology (AGIHO)","volume":"61","author":"Ruhnke","year":"2018","journal-title":"Mycoses"},{"key":"2021120812115643300_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/ajt.13186","article-title":"Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients","volume":"15","author":"Farmakiotis","year":"2015","journal-title":"Am J Transplant"},{"key":"2021120812115643300_bib31","doi-asserted-by":"crossref","first-page":"e12898","DOI":"10.1111\/tid.12898","article-title":"Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the swiss transplant cohort study","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2021120812115643300_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"Aspergillosis in solid organ transplantation","volume":"13 Suppl 4","author":"Singh","year":"2013","journal-title":"Am J Transplant"},{"key":"2021120812115643300_bib33","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1089\/sur.2006.7.s2-93","article-title":"Increasing fungal infections in the intensive care unit","volume":"7 Suppl 2","author":"De Pauw","year":"2006","journal-title":"Surg Infect (Larchmt)"},{"key":"2021120812115643300_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2012.06805.x","article-title":"Invasive aspergillosis in the intensive care unit","volume":"1272","author":"Dimopoulos","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"2021120812115643300_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2011.11.017","article-title":"Invasive fungal infections in patients with cancer in the intensive care unit","volume":"39","author":"Sipsas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"2021120812115643300_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-13-29","article-title":"Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes","volume":"13","author":"Baddley","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2021120812115643300_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/myc.12331","article-title":"Relevance of candida and other mycoses for morbidity and mortality in severe sepsis and septic shock due to peritonitis","volume":"58","author":"Lichtenstern","year":"2015","journal-title":"Mycoses"},{"key":"2021120812115643300_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib39","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the european organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib40","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2021120812115643300_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","article-title":"Invasive fungal infections in the intensive care unit: a multicenter, prospective, observational study in Italy (2006-2008)","volume":"55","author":"Tortorano","year":"2012","journal-title":"Mycoses"},{"key":"2021120812115643300_bib42","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.30.30300","article-title":"Emerging aspergillosis by azole-resistant aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013","volume":"21","author":"van Paassen","year":"2016","journal-title":"Euro Surveill"},{"key":"2021120812115643300_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120812115643300_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00134-014-3526-y","article-title":"Evaluation of 7.5 years of surviving sepsis campaign guidelines","volume":"41","author":"Bakker","year":"2015","journal-title":"Intensive Care Med"},{"key":"2021120812115643300_bib45","first-page":"1396","article-title":"Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome","volume":"79","author":"Blot","year":"2013","journal-title":"Minerva Anestesiol"},{"key":"2021120812115643300_bib46","doi-asserted-by":"crossref","first-page":"e0206089","DOI":"10.1371\/journal.pone.0206089","article-title":"Increased presepsin levels are associated with the severity of fungal bloodstream infections","volume":"13","author":"Bamba","year":"2018","journal-title":"PLoS One"},{"key":"2021120812115643300_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13054-014-0507-z","article-title":"Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment","volume":"18","author":"Behnes","year":"2014","journal-title":"Crit Care"},{"key":"2021120812115643300_bib48","doi-asserted-by":"crossref","first-page":"e00140","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Latg\u00e9","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2021120812115643300_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40121-017-0183-9","article-title":"Challenges and solution of invasive aspergillosis in non-neutropenic patients: a review","volume":"7","author":"Bassetti","year":"2018","journal-title":"Infect Dis Ther"},{"key":"2021120812115643300_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"2021120812115643300_bib51","first-page":"271","article-title":"Invasive pilzinfektionen","volume":"116","author":"von Lilienfeld-Toal","year":"2019","journal-title":"Dtsch Arztebl International"},{"key":"2021120812115643300_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2018.12.020","article-title":"Prevention of healthcare-associated invasive aspergillosis during hospital construction\/renovation works","volume":"103","author":"Talento","year":"2019","journal-title":"J Hosp Infect"},{"key":"2021120812115643300_bib53","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/1841731a0","article-title":"Effect of steroids and related compounds on the growth of dermatophytes","volume":"184","author":"Chattaway","year":"1959","journal-title":"Nature"},{"key":"2021120812115643300_bib54","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1099\/13500872-140-9-2475","article-title":"Hydrocortisone-enhanced growth of aspergillus spp.: implications for pathogenesis","volume":"140","author":"Ng","year":"1994","journal-title":"Microbiology"},{"key":"2021120812115643300_bib55","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"2021120812115643300_bib56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","article-title":"Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality","volume":"59","author":"Vandewoude","year":"2004","journal-title":"Acta Clin Belg"},{"key":"2021120812115643300_bib57","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","article-title":"Clinical risk factors for invasive aspergillosis","volume":"49 Suppl 1","author":"Baddley","year":"2011","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib58","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","article-title":"Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study","volume":"44","author":"Moreno","year":"2018","journal-title":"Intensive Care Med"},{"key":"2021120812115643300_bib59","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM200008243430818","article-title":"Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone","volume":"343","author":"Leav","year":"2000","journal-title":"N Engl J Med"},{"key":"2021120812115643300_bib60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cid\/ciu337","article-title":"Immune correlates of protection in human invasive aspergillosis","volume":"59","author":"Camargo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib61","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","volume":"24","author":"van Paassen","year":"2020","journal-title":"Critical Care"},{"key":"2021120812115643300_bib62","first-page":"m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Rochwerg","year":"2020","journal-title":"BMJ"},{"key":"2021120812115643300_bib63","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"The RECOVERY Collaborative","year":"2020","journal-title":"New Engl J Med"},{"key":"2021120812115643300_bib64","doi-asserted-by":"crossref","first-page":"e00035","DOI":"10.1128\/CMR.00035-19","article-title":"Infectious complications of biological and small molecule targeted immunomodulatory therapies","volume":"33","author":"Davis","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"2021120812115643300_bib65","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ccell.2017.05.004","article-title":"Ibrutinib in PCNSL: the curious cases of clinical responses and aspergillosis","volume":"31","author":"Grommes","year":"2017","journal-title":"Cancer Cell"},{"key":"2021120812115643300_bib66","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"key":"2021120812115643300_bib67","first-page":"27","article-title":"Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia","volume":"21","author":"Arthurs","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"2021120812115643300_bib68","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib69","first-page":"1","article-title":"Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report","author":"Nyga","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"2021120812115643300_bib70","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood-2018-02-832154","article-title":"Ibrutinib and fungus: an invasive concern","volume":"131","author":"Rogers","year":"2018","journal-title":"Blood"},{"key":"2021120812115643300_bib71","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/s41375-019-0481-1","article-title":"Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies","volume":"33","author":"Rogers","year":"2019","journal-title":"Leukemia"},{"key":"2021120812115643300_bib72","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of b cell receptor signaling by ibrutinib in primary CNS lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Cancer Cell"},{"key":"2021120812115643300_bib74","first-page":"1621","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib75","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/bloodadvances.2019000930","article-title":"Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents","volume":"3","author":"Aldoss","year":"2019","journal-title":"Blood Adv"},{"key":"2021120812115643300_bib76","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.cmi.2018.02.009","article-title":"ESCMID study group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)","volume":"24 Suppl 2","author":"Reinwald","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib77","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41375-019-0388-x","article-title":"Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the european conference on infections in leukemia (ECIL)","volume":"33","author":"Maschmeyer","year":"2019","journal-title":"Leukemia"},{"key":"2021120812115643300_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","article-title":"Primary prophylaxis of invasive fungal infections in patients with hematological malignancies: 2017 update of the recommendations of the infectious diseases working party (AGIHO) of the german society for hematology and medical oncology (DGHO)","volume":"97","author":"Mellinghoff","year":"2018","journal-title":"Ann Hematol"},{"key":"2021120812115643300_bib79","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/s41467-018-04912-3","article-title":"Genetic deficiency of NOD2 confers resistance to invasive aspergillosis","volume":"9","author":"Gresnigt","year":"2018","journal-title":"Nat Commun"},{"key":"2021120812115643300_bib80","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/mi.2016.52","article-title":"Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis","volume":"10","author":"Zelante","year":"2017","journal-title":"Mucosal Immunol"},{"key":"2021120812115643300_bib81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N Engl J Med"},{"key":"2021120812115643300_bib82","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1469-0691.2010.03402.x","article-title":"Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals","volume":"17","author":"Garbino","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib83","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc3488","article-title":"Isolation of aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome","volume":"9","author":"Garnacho-Montero","year":"2005","journal-title":"Crit Care"},{"key":"2021120812115643300_bib84","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib85","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","author":"Vandewoude","year":"2006","journal-title":"Crit Care"},{"key":"2021120812115643300_bib86","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eimc.2019.06.007","article-title":"Clinical factors associated with pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"38","author":"Molinos-Castro","year":"2020","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2021120812115643300_bib87","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur Respir J"},{"key":"2021120812115643300_bib88","doi-asserted-by":"crossref","first-page":"1700532","DOI":"10.1183\/13993003.00532-2017","article-title":"Which algorithm diagnoses invasive pulmonary aspergillosis best in ICU patients with COPD?","volume":"50","author":"Bulpa","year":"2017","journal-title":"Eur Respir J"},{"key":"2021120812115643300_bib89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120812115643300_bib90","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib91","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24 Suppl 1","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib92","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J Hepatol"},{"key":"2021120812115643300_bib93","doi-asserted-by":"crossref","first-page":"11919","DOI":"10.1038\/s41598-019-48183-4","article-title":"Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study","volume":"9","author":"Lahmer","year":"2019","journal-title":"Sci Rep"},{"key":"2021120812115643300_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13613-019-0502-2","article-title":"Invasive pulmonary aspergillosis in cirrhotic patients: analysis of a 10-year clinical experience","volume":"9","author":"Levesque","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2021120812115643300_bib95","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2143\/ACB.3408","article-title":"Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years","volume":"68","author":"Jeurissen","year":"2013","journal-title":"Acta Clin Belg"},{"key":"2021120812115643300_bib96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13613-017-0249-6","article-title":"Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis","volume":"7","author":"Weil","year":"2017","journal-title":"Ann Intensive Care"},{"key":"2021120812115643300_bib97","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0300060517729907","article-title":"Epidemiology of invasive pulmonary aspergillosis in patients with liver failure: clinical presentation, risk factors, and outcomes","volume":"46","author":"Zhang","year":"2018","journal-title":"J Int Med Res"},{"key":"2021120812115643300_bib98","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/13693786.2010.535030","article-title":"Invasive aspergillosis in patients with liver disease","volume":"49","author":"Falcone","year":"2011","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib99","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"2021120812115643300_bib100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccc.2016.03.006","article-title":"Infections in liver disease","volume":"32","author":"Nanchal","year":"2016","journal-title":"Crit Care Clin"},{"key":"2021120812115643300_bib101","first-page":"50","article-title":"Immune dysfunction in cirrhosis","volume":"5","author":"Noor","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"2021120812115643300_bib102","first-page":"100","article-title":"Aspergillus tracheobronchitis in influenza B","volume":"116","author":"Frings","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"2021120812115643300_bib103","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/crj.13036","article-title":"Aspergillosis related to severe influenza: a worldwide phenomenon?","volume":"13","author":"Liu","year":"2019","journal-title":"Clin Respir J"},{"key":"2021120812115643300_bib104","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00134-016-4578-y","article-title":"Increased incidence of co-infection in critically ill patients with influenza","volume":"43","author":"Martin-Loeches","year":"2017","journal-title":"Intensive Care Med"},{"key":"2021120812115643300_bib105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","article-title":"Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. A clinical trial","volume":"202","author":"Nyga","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120812115643300_bib106","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"van de Veerdonk","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120812115643300_bib107","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med"},{"key":"2021120812115643300_bib108","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.202005-1883ED","article-title":"Invasive aspergillus tracheobronchitis emerging as a highly lethal complication of severe influenza","volume":"202","author":"van de Veerdonk","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120812115643300_bib109","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","article-title":"Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment","volume":"31","author":"Vanderbeke","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2021120812115643300_bib110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/myc.12926","article-title":"Baseline predictors influencing the prognosis of invasive aspergillosis in adults","volume":"62","author":"Koehler","year":"2019","journal-title":"Mycoses"},{"key":"2021120812115643300_bib111","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.cmi.2019.04.031","article-title":"Intensive care management of influenza-associated pulmonary aspergillosis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib112","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1055\/a-0817-7432","article-title":"[Invasive pulmonary aspergillosis]","volume":"144","author":"Matthews","year":"2019","journal-title":"Dtsch Med Wochenschr"},{"key":"2021120812115643300_bib113","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"key":"2021120812115643300_bib114","author":"ECDC","year":"2018","journal-title":"Influenza-associated invasive pulmonary aspergillosis, Europe. Rapid Risk Assessment"},{"key":"2021120812115643300_bib115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13054-020-02901-x","article-title":"Correction to: international survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe","volume":"24","author":"Thevissen","year":"2020","journal-title":"Crit Care"},{"key":"2021120812115643300_bib116","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13054-020-2808-8","article-title":"International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe","volume":"24","author":"Thevissen","year":"2020","journal-title":"Crit Care"},{"key":"2021120812115643300_bib117","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3201\/eid2604.190953","article-title":"Knowledge of infectious disease specialists regarding aspergillosis complicating influenza, United States","volume":"26","author":"Toda","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2021120812115643300_bib118","article-title":"Influenza- and COVID-19-associated pulmonary aspergillosis: are the pictures different?","volume":"7","author":"Reizine","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2021120812115643300_bib119","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2021120812115643300_bib120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"2021120812115643300_bib121","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3201\/eid2701.202896","article-title":"Aspergillosis complicating severe coronavirus disease","volume":"27","author":"Marr","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2021120812115643300_bib122","article-title":"COVID-19 associated pulmonary aspergillosis in mechanically ventilated patients","author":"Permpalung","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib123","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3389\/fmicb.2020.01401","article-title":"Prevalence and antifungal susceptibility of pathogenic yeasts in China: a 10-Year retrospective study in a teaching hospital","volume":"11","author":"Song","year":"2020","journal-title":"Front Microbiol"},{"key":"2021120812115643300_bib124","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120812115643300_bib125","doi-asserted-by":"crossref","first-page":"e13485","DOI":"10.1111\/tid.13485","article-title":"Zoonotic sporotrichosis in renal transplant recipients from Rio de Janeiro, Brazil","volume":"23","author":"Fichman","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2021120812115643300_bib126","doi-asserted-by":"crossref","first-page":"e0238825","DOI":"10.1371\/journal.pone.0238825","article-title":"Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective aspcovid-19 study","volume":"16","author":"Lahmer","year":"2021","journal-title":"PLoS One"},{"key":"2021120812115643300_bib127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","article-title":"COVID-19 associated with pulmonary aspergillosis: a literature review","volume":"54","author":"Lai","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"2021120812115643300_bib128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cmi.2020.10.021","article-title":"Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors","volume":"27","author":"Ripa","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/myc.13292","article-title":"Incidence and mortality of COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Mitaka","year":"2021","journal-title":"Mycoses"},{"key":"2021120812115643300_bib130","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab163","article-title":"Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA)","author":"Lamoth","year":"2021","journal-title":"J Infect Dis"},{"key":"2021120812115643300_bib131","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"2021120812115643300_bib132","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2021120812115643300_bib133","article-title":"A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU","author":"White","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib134","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1586\/eri.12.50","article-title":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes","volume":"10","author":"Martin","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2021120812115643300_bib135","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"2021120812115643300_bib136","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jss.2011.10.020","article-title":"Viral infections in septic shock (VISS-trial)-crosslinks between inflammation and immunosuppression","volume":"176","author":"Brenner","year":"2012","journal-title":"J Surg Res"},{"key":"2021120812115643300_bib137","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","article-title":"T cells from patients with candida sepsis display a suppressive immunophenotype","volume":"20","author":"Spec","year":"2016","journal-title":"Crit Care"},{"key":"2021120812115643300_bib138","doi-asserted-by":"crossref","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","article-title":"Reactivation of multiple viruses in patients with sepsis","volume":"9","author":"Walton","year":"2014","journal-title":"PLoS ONE"},{"key":"2021120812115643300_bib139","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet North Am Ed"},{"key":"2021120812115643300_bib140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s15010-008-8129-5","article-title":"Occupation, lifestyle, diet, and invasive fungal infections","volume":"36","author":"Sipsas","year":"2008","journal-title":"Infection"},{"key":"2021120812115643300_bib141","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib142","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/myc.12322","article-title":"Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia","volume":"58","author":"Aslan","year":"2015","journal-title":"Mycoses"},{"key":"2021120812115643300_bib143","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis","volume":"41","author":"Heng","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"2021120812115643300_bib144","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/cid\/cix198","article-title":"Pharmacodynamics of isavuconazole for invasive mold disease: role of galactomannan for real-time monitoring of therapeutic response","volume":"64","author":"Kovanda","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib145","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib146","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/myc.12327","article-title":"Performance of lateral flow device and galactomannan for the detection of aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis","volume":"58","author":"Miceli","year":"2015","journal-title":"Mycoses"},{"key":"2021120812115643300_bib147","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/myc.12438","article-title":"The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients","volume":"59","author":"Oz","year":"2016","journal-title":"Mycoses"},{"key":"2021120812115643300_bib148","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jinf.2015.04.005","article-title":"High negative predictive value diagnostic strategies for the reevaluation of early antifungal treatment: a multicenter prospective trial in patients at risk for invasive fungal infections","volume":"71","author":"Hasseine","year":"2015","journal-title":"J Infect"},{"key":"2021120812115643300_bib149","article-title":"Galactomannan and 1,3-beta-d-glucan testing for the diagnosis of invasive aspergillosis","volume":"2","author":"Lamoth","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"2021120812115643300_bib150","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkx030","article-title":"Early diagnosis of invasive mold infections and disease","volume":"72","author":"Lamoth","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021120812115643300_bib151","article-title":"New concepts in diagnostics for invasive mycoses: non-culture-based methodologies","volume":"5","author":"Patterson","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2021120812115643300_bib152","doi-asserted-by":"crossref","first-page":"e43347","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS ONE"},{"key":"2021120812115643300_bib153","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/mmy\/myx011","article-title":"Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study","volume":"55","author":"Prattes","year":"2017","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib154","first-page":"CD012399","article-title":"Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients","volume":"5","author":"de Heer","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120812115643300_bib155","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/14787210.2017.1401467","article-title":"Use of 1,3-beta-D-glucan in invasive fungal diseases in hematology patients","volume":"15","author":"Giacobbe","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2021120812115643300_bib156","first-page":"112","article-title":"Presence of (1-3) beta-d-glucan in patients at risk for invasive fungal infections","volume":"58","author":"Gonzalez","year":"2015","journal-title":"Mycoses"},{"key":"2021120812115643300_bib157","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","article-title":"Diagnostic performance of the (1\u21923) beta-D-Glucan assay for invasive fungal disease","volume":"49","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib158","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","article-title":"Role of (1\u21923)-beta-D-glucan in the diagnosis of invasive aspergillosis","volume":"47 Suppl 1","author":"Marty","year":"2009","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib159","doi-asserted-by":"crossref","first-page":"e0188860","DOI":"10.1371\/journal.pone.0188860","article-title":"Diagnostic performance of the (1-3)-beta-D-glucan assay in patients with pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers","volume":"12","author":"Son","year":"2017","journal-title":"PLoS One"},{"key":"2021120812115643300_bib160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jinf.2014.04.008","article-title":"The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections","volume":"69","author":"Rose","year":"2014","journal-title":"J Infect"},{"key":"2021120812115643300_bib161","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00464-18","article-title":"Comparative analysis of the wako beta-Glucan test and the fungitell assay for diagnosis of candidemia and pneumocystis jirovecii pneumonia","volume":"56","author":"Friedrich","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2021120812115643300_bib162","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/14737159.2017.1325735","article-title":"Evaluating the use of PCR for diagnosing invasive aspergillosis","volume":"17","author":"Buchheidt","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2021120812115643300_bib163","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1128\/JCM.00110-15","article-title":"Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis","volume":"53","author":"Johnson","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2021120812115643300_bib164","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","article-title":"Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official american thoracic society clinical practice guideline","volume":"200","author":"Hage","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120812115643300_bib165","doi-asserted-by":"crossref","first-page":"e01259","DOI":"10.1128\/JCM.01259-19","article-title":"Molecular detection of filamentous fungi in formalin-fixed paraffin-embedded specimens in invasive fungal wound infections is feasible with high specificity","volume":"58","author":"Ganesan","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2021120812115643300_bib166","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10096-018-3251-5","article-title":"Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach","volume":"37","author":"Moura","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021120812115643300_bib167","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib168","first-page":"CD009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120812115643300_bib169","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib170","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciz1013","article-title":"Defining invasive fungal diseases for clinical research: a work in progress","volume":"71","author":"Rogers","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib171","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MCC.0000000000000637","article-title":"Diagnosing invasive pulmonary aspergillosis in ICU patients: putting the puzzle together","volume":"25","author":"Blot","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2021120812115643300_bib172","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/mmy\/myx117","article-title":"Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort","volume":"56","author":"Matthaiou","year":"2017","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib173","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/cid\/cix130","article-title":"Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis","volume":"64","author":"Lamoth","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib174","first-page":"59","article-title":"Prophylaxis of mold infections","volume":"32 Suppl 2","author":"Moreno-Garcia","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"2021120812115643300_bib175","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib176","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1177\/1078155218783248","article-title":"Significant drug interaction between voriconazole and dexamethasone: a case report","volume":"25","author":"Taghvaye Masoumi","year":"2018","journal-title":"Journal of Oncology Pharmacy Practice"},{"key":"2021120812115643300_bib177","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40121-020-00280-y","article-title":"Therapeutic drug monitoring of antifungal drugs: another tool to improve patient outcome?","volume":"9","author":"Vena","year":"2020","journal-title":"Infect Dis Ther"},{"key":"2021120812115643300_bib178","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1007\/s12325-019-01115-0","article-title":"Choosing the right antifungal agent in ICU patients","volume":"36","author":"Chatelon","year":"2019","journal-title":"Adv Ther"},{"key":"2021120812115643300_bib179","doi-asserted-by":"crossref","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases community of practice","author":"Husain","year":"2019","journal-title":"Clin Transplant"},{"key":"2021120812115643300_bib180","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/jac\/dkw099","article-title":"Utility of voriconazole therapeutic drug monitoring: a meta-analysis","volume":"71","author":"Luong","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2021120812115643300_bib181","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib182","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/mmy\/myv099","article-title":"Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels","volume":"54","author":"Guinea","year":"2016","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib183","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/tid.12454","article-title":"Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial","volume":"17","author":"Neofytos","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"2021120812115643300_bib184","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mold disease caused by aspergillus and other filamentous fungi (SECURE): a phase 3, randomized-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"2021120812115643300_bib185","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2021120812115643300_bib186","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"2021120812115643300_bib187","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in aspergillus fumigatus: recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2021120812115643300_bib188","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-018-2023-z","article-title":"Fungal infections in adult patients on extracorporeal life support","volume":"22","author":"Cavayas","year":"2018","journal-title":"Crit Care"},{"key":"2021120812115643300_bib189","first-page":"79","article-title":"Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections","volume":"9","author":"Donnelley","year":"2016","journal-title":"Infect Drug Resist"},{"key":"2021120812115643300_bib190","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01162-19","article-title":"Influence of sustained low-efficiency dialysis treatment on isavuconazole plasma levels in critically ill patients","volume":"63","author":"Lahmer","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021120812115643300_bib191","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1007\/s00330-016-4717-4","article-title":"Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis","volume":"27","author":"Vehreschild","year":"2017","journal-title":"Eur Radiol"},{"key":"2021120812115643300_bib192","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1128\/JCM.00750-11","article-title":"Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients","volume":"50","author":"Bergeron","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021120812115643300_bib193","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JCM.06513-11","article-title":"Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis","volume":"50","author":"Chai","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021120812115643300_bib194","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/cit393","article-title":"The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis","volume":"57","author":"Fisher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10928-017-9509-1","article-title":"Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis","volume":"44","author":"Kovanda","year":"2017","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"2021120812115643300_bib196","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24022","article-title":"Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients","volume":"115","author":"Maertens","year":"2009","journal-title":"Cancer"},{"key":"2021120812115643300_bib197","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fmicb.2018.00661","article-title":"Galactomannan, a surrogate marker for outcome in invasive aspergillosis: finally coming of age","volume":"9","author":"Mercier","year":"2018","journal-title":"Front Microbiol"},{"key":"2021120812115643300_bib198","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cir441","article-title":"Earlier response assessment in invasive aspergillosis based on the kinetics of serum aspergillus galactomannan: proposal for a new definition","volume":"53","author":"Nou\u00e9r","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021120812115643300_bib199","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.22863","article-title":"Serum aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer","volume":"110","author":"Woods","year":"2007","journal-title":"Cancer"},{"key":"2021120812115643300_bib200","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1086\/656527","article-title":"Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive aspergillosis","volume":"202","author":"Chai","year":"2010","journal-title":"J Infect Dis"},{"key":"2021120812115643300_bib201","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2500\/ajra.2015.29.4115","article-title":"Prognostic factors for survival in patients with acute invasive fungal rhinosinusitis","volume":"29","author":"Cho","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"2021120812115643300_bib202","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/AAC.02482-14","article-title":"Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic response","volume":"58","author":"Krel","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021120812115643300_bib203","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/myc.12860","article-title":"Diagnostic work up to assess early response indicators in invasive pulmonary aspergillosis in adult patients with hematologic malignancies","volume":"62","author":"Heinz","year":"2019","journal-title":"Mycoses"},{"key":"2021120812115643300_bib204","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtct.2020.10.003","article-title":"American society of transplantation and cellular therapy series, 2: management and prevention of aspergillosis in hematopoietic cell transplantation recipients","volume":"27","author":"Dadwal","year":"2021","journal-title":"Transplantation and Cellular Therapy"},{"key":"2021120812115643300_bib205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s15010-019-01360-z","article-title":"Invasive mold infections in solid organ transplant patients: modifiers and indicators of disease and treatment response","volume":"47","author":"Welte","year":"2019","journal-title":"Infection"},{"key":"2021120812115643300_bib206","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1093\/mmy\/myy125","article-title":"Beyond biomarkers: how enhanced CT imaging can improve the diagnostic-driven management of invasive mold disease","volume":"57","author":"Stanzani","year":"2019","journal-title":"Med Mycol"},{"key":"2021120812115643300_bib207","article-title":"[Invasive aspergillosis in influenza? Chance or fact?]","volume":"6","author":"Matthews","year":"2018","journal-title":"Intensiv-News"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myab064\/40820680\/myab064.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/1\/myab064\/41646750\/myab064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/1\/myab064\/41646750\/myab064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T12:10:48Z","timestamp":1699704648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myab064\/6408468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,10,22]]},"published-print":{"date-parts":[[2021,12,8]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myab064","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1]]},"published":{"date-parts":[[2021,10,22]]},"article-number":"myab064"}}